Krensavage Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-432,624
Closed -$34.3M 11
2019
Q1
$34.3M Sell
432,624
-18,139
-4% -$1.36M 9.28% 7
2018
Q4
$32.9M Sell
450,763
-84,669
-16% -$5.98M 11.1% 6
2018
Q3
$36.2M Sell
535,432
-4,737
-0.9% -$302K 9.31% 6
2018
Q2
$31.3M Sell
540,169
-38,593
-7% -$2.18M 7.99% 6
2018
Q1
$30.1M Buy
578,762
+411,642
+246% +$22.2M 7.3% 6
2017
Q4
$8.97M Sell
167,120
-234,909
-58% -$13M 2.8% 12
2017
Q3
$24.6M Buy
402,029
+1,238
+0.3% +$75.1K 7.66% 6
2017
Q2
$24.5M Sell
400,791
-2,486
-0.6% -$151K 7.44% 8
2017
Q1
$24.5M Buy
403,277
+138,265
+52% +$8.39M 7.88% 7
2016
Q4
$14.9M Sell
265,012
-5,394
-2% -$316K 5.34% 9
2016
Q3
$16.1M Buy
270,406
+506
+0.2% +$29.6K 5.82% 10
2016
Q2
$14.8M Buy
269,900
+1,379
+0.5% +$73.4K 5.35% 11
2016
Q1
$13.6M Buy
268,521
+1,235
+0.5% +$60.5K 4.86% 11
2015
Q4
$13.5M Buy
267,286
+5,807
+2% +$293K 4.3% 10
2015
Q3
$12.3M Buy
261,479
+28,715
+12% +$1.53M 4.46% 11
2015
Q2
$12.6M Buy
232,764
+13,413
+6% +$752K 4.77% 10
2015
Q1
$12M Buy
219,351
+5,454
+3% +$309K 5.48% 9
2014
Q4
$11.6M Buy
+213,897
New +$11.9M 6.46% 8

Other funds holding MRK

Krensavage Asset Management's MRK Position: Q2 2019 in Review

Krensavage Asset Management sold out of Merck (MRK) in Q2 2019, closing a stake of 432,624 shares — an estimated $34.3M sold.

Krensavage Asset Management first reported a position in MRK in Q4 2014 and held it in 18 quarters. The position peaked at $36.2M in Q3 2018. 2,299 funds tracked by Wall St. Rank hold MRK as of Q2 2019.

  • Krensavage Asset Management reported no remaining Merck position as of Q2 2019 after selling out during the quarter.
  • Krensavage Asset Management sold 432,624 Merck shares in Q2 2019, an estimated $34.3M.
  • Krensavage Asset Management first reported a position in Merck in Q4 2014 and held it in 18 quarters.
  • Krensavage Asset Management's Merck position peaked at $36.2M in Q3 2018.
  • 2,299 funds tracked by Wall St. Rank held Merck as of Q2 2019.

Based on Krensavage Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.